STOCK TITAN

Beneficient (BENF) SEC Filings

BENF NASDAQ

Beneficient filings document the regulatory record for a Nevada financial services company that provides alternative-asset exit opportunities, primary capital solutions, and related trust and custody services. Its disclosures cover Class A common stock, warrants, convertible preferred stock, customized trust vehicles, limited partner interests, and securities issued in primary capital transactions.

The company’s SEC filings include 8-K reports on operating results, unregistered equity issuances, debt agreements and repayments, litigation settlement matters, and other material events. Proxy materials document annual meeting proposals, shareholder voting results, incentive-plan amendments, board and governance matters, while periodic and exhibit disclosures provide additional information on financial condition, risk factors, and capital structure.

Rhea-AI Summary

Beneficient (BENF) reported a $39.370 million consolidated net loss for the quarter ended September 30, 2026, compared with $17.907 million a year earlier. Total revenues were negative $25.286 million, versus negative $2.763 million, reflecting investment and financial-instrument losses. Net loss attributable to common shareholders was $22.056 million, compared with $3.629 million. For the six months, common-shareholder net loss was $28.839 million, compared with $68.705 million, and operating cash used was $14.156 million, compared with $25.364 million.

At September 30, 2026, cash and cash equivalents were $7.476 million, total liabilities were $353.808 million, and shareholders’ equity was a $217.053 million deficit. The company recorded a $1.479 million goodwill impairment charge in the quarter. It converted approximately $2.7 million of convertible promissory notes into 2,621,609 Class A shares, leaving approximately $1.3 million of principal outstanding. Beneficient said its inability to raise sufficient capital, recurring operating losses, negative operating cash flows and other stated factors raise substantial doubt about its ability to continue as a going concern.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Beneficient (BENF) reported fiscal 2027 second-quarter results for the three months ended September 30, 2026. GAAP revenue was negative $25.286 million, compared with negative $2.763 million in fiscal 2026’s second quarter; net loss attributable to Beneficient common shareholders was $22.056 million versus $3.629 million. Operating expenses were $14.062 million, down 6.9% from $15.101 million. At quarter-end, cash and cash equivalents were $7.476 million and total debt was $98.1 million.

Beneficient closed a $7.4 million GP Primary Capital transaction during the quarter and said primary capital transactions with two funds had increased collateral by more than $16 million to date in fiscal 2027. Asset sales and equity redemptions generated $60.5 million in cumulative gross proceeds from the prior fiscal year’s inception through September 30, 2026; proceeds were used for debt paydown and working capital. Investments at fair value of $201.0 million supported a $172.3 million net loan portfolio. The company also announced plans to launch AltLens, a portfolio analytics and risk platform for family offices and small institutional investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Beneficient received a Nasdaq notice on November 5, 2026, stating that its market value of listed securities (MVLS) was below the $35 million continued-listing minimum for 30 consecutive business days, from September 24 through November 4. Nasdaq also said the company did not meet alternative standards for minimum stockholders’ equity or net income from continuing operations. The notice has no immediate effect on trading: Beneficient’s Class A common stock and warrants continue to trade on The Nasdaq Capital Market.

Beneficient has an initial compliance period of 180 calendar days, through May 4, 2027, to regain compliance with the MVLS requirement. Nasdaq will confirm compliance if MVLS closes at $35 million or more for at least 10 consecutive business days, though it may require a longer period, generally no more than 20 consecutive business days. If Beneficient does not regain compliance by the deadline, Nasdaq will notify it that its securities are subject to delisting; the company may appeal that determination to a Nasdaq Hearings Panel. Beneficient is evaluating options, but there is no assurance it will regain compliance by the deadline.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.71%
Tags
current report
Rhea-AI Summary

At its October 29, 2026 special meeting, Beneficient stockholders approved Proposal 1, authorizing the issuance of Class A common stock to Yorkville under the Amended and Restated Standby Equity Purchase Agreement and convertible promissory notes with an original aggregate principal amount of $4.0 million. The proposal was for purposes of Nasdaq Listing Rule 5635(d); the shares may represent more than 20% of common stock outstanding as of the agreement date.

The Proposal 1 results table reported 13,920,141 votes for, 328,427 against and 5,061 abstentions. Separately, excluding the 2,902,240 Yorkville Shares issued before the record date, the company reported 11,017,901 votes for and 328,427 against. Proposal 2, to permit an adjournment if needed, was approved, but an adjournment was unnecessary because there were sufficient votes for Proposal 1. The meeting represented approximately 74.0% of the company’s total voting power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.58%
Tags
current report
-
Rhea-AI Summary

Beneficient director Patrick J. Donegan reported direct awards of fully vested RSUs covering 30,660 shares and 61,321 shares on September 18, 2026, and 23,897 shares on September 30, 2026. The underlying Class A common shares are issuable upon settlement of the RSUs. The 61,321-RSU award was granted in satisfaction of prior service compensation for October 1, 2025 through March 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.88%
Tags
insider
-
Form 8-K
Rhea-AI Summary

Beneficient (BENF) and certain subsidiaries filed a motion to intervene in HCLP Nominees, L.L.C.’s Delaware Court of Chancery litigation against Delaware Trust Company on October 23, 2026. The proposed verified complaint seeks to invalidate HCLP credit agreements and related loan documents, cancel the purported obligations, recover approximately $211 million the company previously paid on the purported debt, and establish that HCLP has no valid right to related collateral.

If successful, the action would eliminate approximately $130 million of purported HCLP debt. Beneficient said it is also pursuing a potential consensual resolution addressing the debt, the equity and governance interests of its former Chief Executive Officer, Brad Heppner, and his affiliated entities, and remaining contractual arrangements with them. The proposed complaint is subject to the court granting the motion to intervene, and no definitive agreement concerning a consensual resolution has been reached. Beneficient said neither negotiations nor litigation assures a particular outcome.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
current report
Rhea-AI Summary

Beneficient director Peter T. Cangany Jr. received an award of 25,689 restricted stock units (RSUs) tied to Class A common stock on September 30, 2026. The RSUs fully vested on the grant date, and the shares are issuable upon settlement under the Beneficient 2023 Equity Incentive Plan. The report lists 404,820 shares held directly after the award. It separately lists 40,625 shares held by Cangany Capital Management, LLC and 12,500 shares held by The Cangany Group, LLC; Cangany disclaims beneficial ownership of the LLC-held securities except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider
-
Rhea-AI Summary

Beneficient director Bruce William Schnitzer received an award of 23,300 restricted stock units on September 30, 2026. The RSUs fully vested on the grant date and are issuable upon settlement for Class A common stock. His reported holdings following the transaction were 536,853 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider
-
Rhea-AI Summary

Beneficient director and 10% owner Mack H. Hicks acquired a fully vested award of 20,910 restricted stock units (RSUs) on September 30, 2026, under the Beneficient 2023 Equity Incentive Plan. The units represent Class A common shares issuable upon settlement. His reported direct holdings after the award were 47,738 shares, including 26,828 shares issuable upon settlement of RSUs granted and fully vested on September 18, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider
Rhea-AI Summary

Beneficient director Karen Wendel received an award of 25,689 restricted stock units on September 30, 2026. The RSUs fully vested on the grant date and are issuable as Class A common stock upon settlement. Wendel reported 128,579 shares following the transaction, including shares issuable upon settlement of other RSU awards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider

FAQ

How many Beneficient (BENF) SEC filings are available on StockTitan?

StockTitan tracks 86 SEC filings for Beneficient (BENF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Beneficient (BENF)?

The most recent SEC filing for Beneficient (BENF) was filed on November 16, 2026.